Targeting FoxM1 over-expressing BC with thiostrepton either accompanied with chemotherapy or as maintenance after chemotherapy maybe beneficial in these aggressive cancers that currently have no identified therapeutic targets that can be targeted for management. This evidence concerns the gene FOXM1 and breast cancer.